Sarah Kremen

Mar 4, 2024 | jamanetwork.com | Lauren R. Moo |David B. Reuben |Sarah Kremen |Donovan T. Maust

Longitudinal Management of Dementia in Primary Care Ensuring that the health care system is prepared to provide excellent support and treatment to patients with dementia and their caregivers is imperative. Primary care clinicians (PCCs) are uniquely positioned to recognize, assess, and manage dementia through its many stages thanks to their longitudinal relationships with and their understanding of patients’ larger psychosocial contexts.

Mar 20, 2023 | bottomlineinc.com | Sarah Kremen |Tom Cioffi

Just two years after the aducanumab (Aduhelm) controversy, the U.S. Food and Drug Administration has approved another drug for Alzheimer’s disease. This medication, lecanemab (Leqembi), certainly fared better in clinical trials, though it’s still a far cry from the kind of miracle drug the world is hoping for. Let’s take a look at what we know so far. What does it do?